These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1993423)

  • 41. [Nutritional management in cardiovascular diseases].
    Takahashi H
    Rinsho Byori; 2003 Oct; Suppl 127():52-9. PubMed ID: 14653215
    [No Abstract]   [Full Text] [Related]  

  • 42. Using designer margarines to control lipid levels.
    Cerrato PL
    RN; 1999 Oct; 62(10):67-8. PubMed ID: 10578956
    [No Abstract]   [Full Text] [Related]  

  • 43. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 44. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular disease and lipid management in New Zealand: progress at last!
    Ellis CJ; Scott R
    N Z Med J; 2002 Apr; 115(1152):197-9. PubMed ID: 12044006
    [No Abstract]   [Full Text] [Related]  

  • 46. [Screening and treatment of hyperlipidemias in Israel].
    Sehayek E; Eisenberg S
    Harefuah; 1995 May; 128(9):529-32, 600. PubMed ID: 7797148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemorheologic effects of a short-term ketogenetic diet.
    Peyreigne C; Bouix D; Aïssa Benhaddad A; Raynaud E; Pérez-Martin A; Mercier J; Brun JF
    Clin Hemorheol Microcirc; 1999; 21(2):147-53. PubMed ID: 10599598
    [No Abstract]   [Full Text] [Related]  

  • 48. [Artificial saccharose substitutes in diseases with disordered carbohydrate and lipid metabolism].
    Germaniuk IaL
    Vrach Delo; 1986 Aug; (8):63-7. PubMed ID: 3535254
    [No Abstract]   [Full Text] [Related]  

  • 49. Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.
    Rom O; Villacorta L; Zhang J; Chen YE; Aviram M
    Curr Opin Lipidol; 2018 Oct; 29(5):428-432. PubMed ID: 30153136
    [No Abstract]   [Full Text] [Related]  

  • 50. Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health.
    Hayward RA; Krumholz HM
    Circ Cardiovasc Qual Outcomes; 2012 Jan; 5(1):2-5. PubMed ID: 22253366
    [No Abstract]   [Full Text] [Related]  

  • 51. Should high lipid levels in very old patients be lowered?
    LaRosa JC
    Drugs Aging; 1995 Feb; 6(2):85-90. PubMed ID: 7711362
    [No Abstract]   [Full Text] [Related]  

  • 52. [TREATMENT OF LIPID METABOLISM DISORDERS WITH ETHYL ALPHA-(P-CHLOROPHENOXY)-ISOBUTYRATE].
    WAGENER H; FROSCH B
    Med Klin; 1964 Nov; 59():1872-5. PubMed ID: 14331763
    [No Abstract]   [Full Text] [Related]  

  • 53. Israel Society for Metabolic Diseases, winter meeting Hadassah Medical Centre, Ein Kerem, Jerusalem, Israel (December 7, 2011).
    Luder A
    Pediatr Endocrinol Rev; 2012 Mar; 9(3):680-1. PubMed ID: 22523837
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiovascular death and disability can be reduced more than 50 percent.
    Indian J Med Sci; 2003 Mar; 57(3):117-21. PubMed ID: 14514263
    [No Abstract]   [Full Text] [Related]  

  • 55. Lipids and the heart: neither feast nor famine.
    Glenn DJ; Gardner DG
    Hypertension; 2007 Sep; 50(3):463-4. PubMed ID: 17664386
    [No Abstract]   [Full Text] [Related]  

  • 56. [Symposium on the disturbance of the lipid metabolism in clinical field (author's transl)].
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1231-84. PubMed ID: 7462750
    [No Abstract]   [Full Text] [Related]  

  • 57. [Symposium on the disturbance of the lipid metabolism in clinical field: concluding remarks (author's transl)].
    Takahashi Y
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1273-5. PubMed ID: 7462760
    [No Abstract]   [Full Text] [Related]  

  • 58. [Muscle metabolism disorder associated with renal malformation].
    Tîrnoveanu G; Georgescu M; Mitescu G
    Rev Med Chir Soc Med Nat Iasi; 1967; 71(1):207-10. PubMed ID: 6062652
    [No Abstract]   [Full Text] [Related]  

  • 59. Lipids in metabolic diseases.
    Dugail I; Kalopissis A; Miquel M; Rainteau D; Zachowski A; Forest C
    Biochimie; 2014 Jan; 96():1-2. PubMed ID: 24321080
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolic hypertension: concept and practice.
    Zhu Z; Wang P; Ma S
    Front Med; 2013 Jun; 7(2):201-6. PubMed ID: 23564405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.